Drug Trial Radar · NCT07767903
A Trial of the Efficacy and Safety of a Fixed Dose of SEP-363856 in Adults With Generalized Anxiety Disorder
Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
384
Planned (sponsor's estimate)
Start
Aug 6, 2026
Primary completion
Oct 25, 2028
Study completion Nov 1, 2028
Sponsor
- Lead sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.Otsuka
- Sponsor type
- Industry
- First posted
- Aug 17, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a global, phase 3, randomized, double-blind, parallel-group, 2-arm, placebo controlled, multicenter trial designed to compare the efficacy, safety and tolerability of a fixed dose of SEP-363856 (75 millligrams per day \[mg/day\]) to placebo over an 8-week double-blind treatment period in adults with generalized anxiety disorder (GAD).
Conditions
- Generalized Anxiety Disorder
Interventions
SEP-363856Drug
Oral tablet
PlaceboDrug
Oral tablet
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline at Week 8 in Hamilton Anxiety Rating Scale (HAM-A) Total ScoreTime frame: Baseline, Week 8
Locations
21 sites in 1 country. Site status is shown where the registry gives one.
IMA Clinical Research - Phoenix
Phoenix, Arizona · Recruiting
Calneuro Research Group
Los Angeles, California · Recruiting
Anderson Clinical Research
Redlands, California · Recruiting
Schuster Medical Research Institute SMRI
Sherman Oaks, California · Recruiting
Concierge Clinical Trials
Valley Village, California · Recruiting
Velocity Clinical Research - Hallandale Beach
Hallandale, Florida · Recruiting
Clinical Neuroscience Solutions Inc. (CNS) - Orlando
Orlando, Florida · Recruiting
ActivMed Practices & Research, LLC
Methuen, Massachusetts · Recruiting
Adams Clinical - Watertown
Watertown, Massachusetts · Recruiting
Lumina Clinical Research Center
Cherry Hill, New Jersey · Recruiting
Basil Clinical
Jamaica, New York · Recruiting
IMA Clinical Research NYC Uptown
New York, New York · Recruiting
Adams Clinical - Bronx
The Bronx, New York · Recruiting
Paradigm Research Professionals LLC
Oklahoma City, Oklahoma · Recruiting
Summit Research Network
Portland, Oregon · Recruiting
Adams Clinical Philadelphia
Philadelphia, Pennsylvania · Recruiting
CNS Healthcare - Memphis
Memphis, Tennessee · Recruiting
Donald J. Garcia, Jr, MD, PA
Austin, Texas · Recruiting
DM Clinical Research - Bellaire
Houston, Texas · Recruiting
Vitra Behavioral and Metabolic Research Center
Fairfax, Virginia · Recruiting
Core Clinical Research
Everett, Washington · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.